153 related articles for article (PubMed ID: 11812437)
1. Transthyretin Ser-44 mutation in a case with vitreous amyloidosis.
Murakami A; Fujiki K; Hasegawa S; Imamura S; Kawano H; Kanai A; Matsumoto T
Am J Ophthalmol; 2002 Feb; 133(2):272-3. PubMed ID: 11812437
[TBL] [Abstract][Full Text] [Related]
2. [Transthyretin Arg-83 mutation in vitreous amyloidosis].
Chen L; Lü L; Zhang P; Li Y; Lin J
Yan Ke Xue Bao; 2008 Mar; 24(1):65-7. PubMed ID: 18709962
[TBL] [Abstract][Full Text] [Related]
3. Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.
Roe RH; Fisher Y; Eagle RC; Fine HF; Cunningham ET
Ophthalmology; 2007 Nov; 114(11):e33-7. PubMed ID: 17980738
[TBL] [Abstract][Full Text] [Related]
4. A new transthyretin mutation associated with amyloidotic vitreous opacities. Asparagine for isoleucine at position 84.
Skinner M; Harding J; Skare I; Jones LA; Cohen AS; Milunsky A; Skare J
Ophthalmology; 1992 Apr; 99(4):503-8. PubMed ID: 1350083
[TBL] [Abstract][Full Text] [Related]
5. Vitreous amyloidosis in two large mainland Chinese kindreds resulting from transthyretin variant Lys35Thr and Leu55Arg.
Long D; Zeng J; Wu LQ; Tang LS; Wang HL; Wang H
Ophthalmic Genet; 2012 Mar; 33(1):28-33. PubMed ID: 21843040
[TBL] [Abstract][Full Text] [Related]
6. A rare transthyretin mutation (Asp18Glu) associated with vitreous amyloid.
Solano JM; Pulido JS; Salomao DR
Ophthalmic Genet; 2007 Jun; 28(2):73-5. PubMed ID: 17558848
[TBL] [Abstract][Full Text] [Related]
7. Vitreous amyloidosis in alanine 71 transthyretin mutation.
Zambarakji HJ; Charteris DG; Ayliffe W; Luthert PJ; Schon F; Hawkins PN
Br J Ophthalmol; 2005 Jun; 89(6):773-4. PubMed ID: 15923520
[No Abstract] [Full Text] [Related]
8. Transthyretin amyloidosis associated with a novel variant (Trp41Leu) presenting with vitreous opacities.
Yazaki M; Connors LH; Eagle RC; Leff SR; Skinner M; Benson MD
Amyloid; 2002 Dec; 9(4):263-7. PubMed ID: 12557756
[TBL] [Abstract][Full Text] [Related]
9. Vitreous amyloidosis in familial amyloidotic polyneuropathy. Report of a case with the Val30Met transthyretin mutation.
Ciulla TA; Tolentino F; Morrow JF; Dryja TP
Surv Ophthalmol; 1995; 40(3):197-206. PubMed ID: 8599155
[TBL] [Abstract][Full Text] [Related]
10. Vitreous amyloidosis associated with homozygosity for the transthyretin methionine-30 gene.
Sandgren O; Holmgren G; Lundgren E
Arch Ophthalmol; 1990 Nov; 108(11):1584-6. PubMed ID: 1978774
[TBL] [Abstract][Full Text] [Related]
11. Transthyretin-related TTR hereditary amyloidosis of the vitreous body. Clinical and molecular characterization in two Italian families.
Salvi F; Salvi G; Volpe R; Mencucci R; Plasmati R; Michelucci R; Gobbi P; Santangelo M; Ferlini A; Forabosco A
Ophthalmic Paediatr Genet; 1993 Mar; 14(1):9-16. PubMed ID: 8345958
[TBL] [Abstract][Full Text] [Related]
12. Restriction fragment length polymorphism analysis of mutated transthyretin in vitreous amyloidosis.
Sandgren O; Holmgren G; Lundgren E; Steen L
Arch Ophthalmol; 1988 Jun; 106(6):790-2. PubMed ID: 2897192
[TBL] [Abstract][Full Text] [Related]
13. A new Arg54Gly transthyretin gene mutation associated with vitreous amyloidosis in Chinese.
Shi Y; Li J; Hu J; Hu J; Sun L; Li H; Shi R; Yang L; Sun Y; Li C
Eye Sci; 2011 Dec; 26(4):230-8. PubMed ID: 22187309
[TBL] [Abstract][Full Text] [Related]
14. Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor.
Zou X; Dong F; Zhang S; Tian R; Sui R
Exp Eye Res; 2013 May; 110():44-9. PubMed ID: 23438977
[TBL] [Abstract][Full Text] [Related]
15. A case of familial amyloid polyneuropathy due to Phe33Val TTR with vitreous involvement as the initial manifestation.
Kono S; Manabe Y; Tanaka T; Fujii D; Sakai Y; Narai H; Omori N; Ueda M; Ando Y; Abe K
Intern Med; 2010; 49(12):1213-6. PubMed ID: 20558946
[TBL] [Abstract][Full Text] [Related]
16. Transthyretin Arg-83 mutation in vitreous amyloidosis.
Chen LY; Lu L; Li YH; Zhong H; Fang W; Zhang L; Li WL
Int J Ophthalmol; 2011; 4(3):329-31. PubMed ID: 22553674
[TBL] [Abstract][Full Text] [Related]
17. Isolated vitreoretinal amyloidosis in the absence of transthyretin mutations.
Barouch FC; Benson MD; Mukai S
Arch Ophthalmol; 2004 Jan; 122(1):123-5. PubMed ID: 14718311
[No Abstract] [Full Text] [Related]
18. Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His.
Blevins G; Macaulay R; Harder S; Fladeland D; Yamashita T; Yazaki M; Hamidi Asl K; Benson MD; Donat JR
Neurology; 2003 May; 60(10):1625-30. PubMed ID: 12771253
[TBL] [Abstract][Full Text] [Related]
19. Familial amyloid with a transthyretin leucine 33 mutation presenting with ascites.
Myers TJ; Kyle RA; Jacobson DR
Am J Hematol; 1998 Nov; 59(3):249-51. PubMed ID: 9798666
[TBL] [Abstract][Full Text] [Related]
20. Considering amyloidosis in patients with clinically unresponsive vitreous inflammation (Oculoleptomeningeal amyloidosis in 3 individuals with transthyretin variant Tyr69His. Vol. 44[3]).
Roe RH; Cunningham ET
Can J Ophthalmol; 2010 Feb; 45(1):81. PubMed ID: 20130721
[No Abstract] [Full Text] [Related]
[Next] [New Search]
